The findings of the present study demonstrated for the first time that acrolein at doses relevant to human exposure significantly inhibited glucose transport via the inhibition of Akt-regulated GLUT4 signaling in skeletal myotubes and impaired glucose tolerance in mice. This evidence concerns the gene AKT1 and Impaired glucose tolerance.